ChatGPT has Potential to Help Cirrhosis, Liver Cancer Patients

A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge, lifestyle and treatments for these conditions.

The findings, published in the peer-reviewed journal Clinical and Molecular Hepatology, highlights the AI system’s potential to play a role in clinical practice.

"Patients with cirrhosis and/or liver cancer and their caregivers often have unmet needs and insufficient knowledge about managing and preventing complications of their disease," said Brennan Spiegel, MD, MSHS, director of Health Services Research at Cedars-Sinai and co-corresponding author of the study. "We found ChatGPT - while it has limitations - can help empower patients and improve health literacy for different populations."

Patients diagnosed with liver cancer and cirrhosis, an end-stage liver disease that is also a major risk factor for the most common form of liver cancer, often require extensive treatment that can be complex and challenging to manage.

"The complexity of the care required for this patient population makes patient empowerment with knowledge about their disease crucial for optimal outcomes," said Alexander Kuo, MD, medical director of Liver Transplantation Medicine at Cedars-Sinai and co-corresponding author of the study. "While there are currently online resources for patients and caregivers, the literature available is often lengthy and difficult for many to understand, highlighting the limited options for this group."

Personalized education AI models could help increase patient knowledge and education, noted Kuo.

One of those is ChatGPT, which stands for generative pre-trained transformer. It has quickly become popular for its human-like text in chatbot conversations where users can input any prompt and it will generate a response based on the information stored in its database.

It has already shown some potential for medical professionals by writing basic medical reports and correctly answering medical student examination questions.

"ChatGPT has shown to be able to provide professional, yet highly comprehensible responses," said Yee Hui Yeo, MD, first author of the study and a clinical fellow in the Karsh Division of Gastroenterology and Hepatology at Cedars-Sinai. "However, this is one of the first studies to examine the ability of ChatGPT to answer clinically oriented, disease-specific questions correctly and compare its performance to physicians and trainees."

To verify the accuracy of the AI model in its knowledge about both cirrhosis and liver cancer, investigators presented ChatGPT with 164 frequently asked questions in five categories. The ChatGPT answers were then graded independently by two liver transplant specialists.

Each question was posed twice to ChatGPT and was categorized as either basic knowledge, diagnosis, treatment, lifestyle or preventive medicine.

Study results include:

  • ChatGPT answered about 77% of the questions correctly, providing high levels of accuracy in 91 questions from a variety of categories.
  • The specialists grading the responses said 75% of the responses for basic knowledge, treatment and lifestyle were comprehensive or correct, but inadequate.
  • The proportion of responses that were "mixed with correct and incorrect data" was 22% for basic knowledge, 33% for diagnosis, 25% for treatment, 18% for lifestyle and 50% for preventive medicine.
  • The AI model also provided practical and useful advice to patients and caregivers regarding the next steps adjusting to a new diagnosis.

Still, the study left no doubt that advice from a physician was superior.

"While the model was able to demonstrate strong capability in the basic knowledge, lifestyle and treatment domains, it suffered on the ability to provide tailored recommendations according to the region where the inquirer lived," said Yeo. "This is most likely due to the varied recommendations in liver cancer surveillance interval and indications reported by different professional societies. But we are hopeful that it will be more accurate in addressing the questions according to the inquirers' location."

"More research is still needed to better examine the tool in patient education, but we believe ChatGPT to be a very useful adjunctive tool for physicians - not a replacement - but adjunctive tool that provides access to reliable and accurate health information that is easy for many to understand," Spiegel said. "We hope that this can help physicians to empower patients and improve health literacy for patients facing challenging conditions such as cirrhosis and liver cancer."

Yeo YH, Samaan JS, Ng WH, Ting PS, Trivedi H, Vipani A, Ayoub W, Yang JD, Liran O, Spiegel B, Kuo A.
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma.
Clin Mol Hepatol. 2023 Mar 22. doi: 10.3350/cmh.2023.0089

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...